ADC Therapeutics Expands Team

ADC Therapeutics (ADCT, a portfolio company of Auven Therapeutics) the oncology drug development company focused on Antibody Drug Conjugates (ADCs) targeting major cancers, today announced a significant expansion of its team as the Company’s first ADCs enter clinical development.

Help employers find you! Check out all the jobs and post your resume.

Back to news